Clinical Trials

90 enrolled

Esophageal Squamous Cell Carcinoma

NCT07379047 2026-04-24

GISTAR-1

255 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT07544056 2026-04-22

A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer

446 enrolled

Breast

Triple Negative Breast Neoplasms

NCT07459751 2026-03-10

A Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43 Monotherapy or HLX43 in Combination With HLX07 Versus Docetaxel in Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

671 enrolled

Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

NCT07255872 2026-03-05

A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia

Other hematologic neoplasm

216 enrolled

Leukemia, Myeloid, Acute

NCT07428369 2026-02-23

LINKER-MM8

1,570 enrolled

Plasma cell

Multiple Myeloma

NCT07392866 2026-02-09

A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma

120 enrolled

Carcinoma, Hepatocellular

NCT07349693 2026-01-20

Cerebraca-02/3

175 enrolled

CNS

Glioblastoma

NCT07332533 2026-01-12

A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer

490 enrolled

HER2-positive Gastric Cancer

NCT07321847 2026-01-07

INJECTABL-3

717 enrolled

Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT07318883 2026-01-06

A Phase II/III Clinical Study to Evaluate HLX07 in Combination With Serplulimab and Chemotherapy Versus Placebo in Combination With Serplulimab or Pembrolizumab and Chemotherapy as First-Line Treatment in Advanced Squamous Non-Small Cell Lung Cancer

720 enrolled

Squamous NSCLC

NCT07294534 2025-12-19

A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX87in Combination With HLX22 or Pertuzumab in the Neoadjuvant Therapy of HER2-Positive Bresat Cancer

817 enrolled

Breast

Breast Neoplasms

NCT07251062 2025-11-26

A Study of SYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.

737 enrolled

Esophageal Squamous Cell Carcinoma

NCT07177716 2025-09-17

Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced Recurrent/Metastatic Cervical Cancer

120 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT07157514 2025-09-10

Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML

Other hematologic neoplasm

306 enrolled

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT06908772 2025-04-03

Glumetinib Combined With Osimertinib Treatment for Non-Small Cell Lung Cancer Patients

390 enrolled

Recurrence

NCT06719479 2024-12-05

A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).

60 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT06548347 2024-08-12

A Phase II/III Study of Linperlisib Plus CHOP Versus CHOP in Patients With Newly Diagnosed Peripheral T Cell Lymphoma

606 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral

NCT05924776 2024-07-22

Plasmodium Immunotherapy for Advanced Ovarian Cancer

30 enrolled

Malaria, Vivax

NCT06335355 2024-03-28

A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients

401 enrolled

Non-squamous Non-small Cell Lung Cancer

NCT06319313 2024-03-20

Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer

534 enrolled

Squamous Cell Non-small Cell Lung Cancer

NCT06211023 2024-01-18

A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer

520 enrolled

Gynecologic

Ovarian Neoplasms

NCT05976568 2023-08-04

A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

668 enrolled